Ferring Pharmaceuticals
As of the edition of 20 October 2026, Ferring Pharmaceuticals runs 38 drugs, 27 of them marketed; it is on route A at 1 target and on route B at 0 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 27 |
| Active | 1 |
| Went quiet | 7 |
| Stopped | 3 |
| Total | 38 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Budesonide | Ends 2029 (exclusivity) | 5 |
| Somatropin | Ended 2003 (orphan exclusivity) | 4 |
| Progesterone | none listed | 3 |
| Degarelix | none listed | 1 |
| Triptorelin | none listed | 0 |
| Mesalamine | Ends 2027 (patent) | 12 |
| Desmopressin | none listed | 0 |
| Gonadotropin, chorionic | Ended 1985 (computed from the first US licence) | 0 |
| Terlipressin | Ends 2029 (exclusivity) | 3 |
| Carbetocin | none listed | 0 |
| Dinoprostone | none listed | 3 |
| Menotropins | Ended 1987 (computed from the first US licence) | 2 |
| Gonadorelin | none listed | 0 |
| Follitropin delta | none listed | 0 |
| Citric acid | none listed | 0 |
| Picosulfuric acid | none listed | 0 |
| Magnesium oxide | none listed | 0 |
| Atosiban | none listed | 0 |
| Follitropin | none listed | 0 |
| Elobixibat | none listed | 1 |
| Urofollitropin | none listed | 1 |
| Nadofaragene firadenovec | Ends 2034 (reference-product exclusivity) | 0 |
| Triptorelin acetate | none listed | 0 |
| Secretin | none listed | 0 |
| Protirelin | none listed | 0 |
A route B row is one company at one target. 2 more marketed drugs are not listed here.
Where it needs a new molecule
Route A at 1 target, route B at 0 targets.
| Target | Route |
|---|---|
| MAPK14 Mitogen-activated protein kinase 14 | Route A |
All 1 row on route A or B
In the product1 company-target row on route A or B; 0 are not shown here, and no score is.
See all 1 targets where Ferring Pharmaceuticals needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Urinary and reproductive: 52 trials led
- Cancer: 41 trials led
- Pregnancy and women's health: 10 trials led